Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Intrigued by the $10M target
View:
Post by N0taP00p on Jun 17, 2024 3:55pm

Intrigued by the $10M target

Like many here, I'm guessing it's going to be an extremely embarrassing PP given the recent muted raises,  or,  a guaranteed source who's going to mop up whatever's left on the offer on the 21st.  Just hoping that it's not the former, where Theralase drank their own Koolaid after releasing back to back NRs about the potential for Ruvidar,  and assumed investors will suddenly forget past hiccups. Bought a few thousand.  We'll know in 4 days or earlier.  Keeping expectations (very) low.
Comment by plantrader on Jun 17, 2024 4:03pm
You nailed my binary guess. Either an embarrassing fumble of a PP, similar to the previous one, or they know that they've already got a substantial chunk lined up. Hopefully someday something surprisingly good happens from a stock perspective, since we've already had a lot of good news that the market shrugged off. Many here seem to think that time is now. But many have felt that way ...more  
Comment by TriumphSpitSix on Jun 17, 2024 4:29pm
I'm going with the likelihood that they already have buyers lined up. Surely they wouldn't make such a high prediction with the past couple dismal PPs still fresh in mind. "We didn't meet our targets on low financings so let's make this next one 10x higher and hope for the best?" Does not compute.
Comment by plantrader on Jun 17, 2024 4:33pm
I agree, that would make no sense. But like notpoop said, is it possible they were predicting those 4 PRs would run up the stock and create momentum or excitement for the PP? Sure hope they have things already lined up, instead. 
Comment by beenthere on Jun 17, 2024 6:10pm
Nothing changes here! " Sure hope they have things already lined up, instead" NO!
Comment by beenthere on Jun 17, 2024 6:11pm
Why do you think the price is where it is? DUH!!!
Comment by plantrader on Jun 17, 2024 6:28pm
Thank you to captain obvious. Everyone here knows they're all waiting for delivery and execution to happen in a substantive way. Even those who constantly make big predictions that don't come to fruition, know it. 
Comment by beenthere on Jun 17, 2024 8:06pm
Maybe? We will soon find out .......in a year or two!
Comment by N0taP00p on Jun 17, 2024 5:10pm
Triumph: if indeed, that's the case, then Friday will be a tug of war between the perception of MC dilution (~100 Million shares with warrants) vs getting rid of the overhang of being perpetually underfunded. 
Comment by TriumphSpitSix on Jun 17, 2024 5:41pm
Agreed. Paradoxically however, the problem of dilution can be resolved by no longer being underfunded such that they can accomplish their goals and inspire price appreciation. Hopefully. Of course, if they didn't ever raise money we wouldn't have the dilution problem, but we also wouldn't have a company. So, begrudgingly, I'll take dilution.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250